About: Board of Directors

Mark D. Myslinski

Mr. Myslinski brings nearly thirty years of life sciences and diagnostics industry experience to the RedPath Board of Directors, including key sales and operating roles in both Fortune 100 and venture-backed start-up organizations. Mr. Myslinski is currently the Senior VP and General Manager of Hologic, Inc.'s diagnostic businesses. Previously he has been a Johnson & Johnson executive where for five years, Mr. Myslinski was General Manager of Johnson & Johnson's Veridex, LLC, a division focused on molecular and cellular diagnostics that achieved rapid sales growth under Mr. Myslinski's tenure. Previously, Mr. Myslinski held executive roles in venture-backed start-ups, Interscope Technologies and Precision Therapeutics, both focused on the field of pathology with an emphasis on cancer. Mr. Myslinski also accumulated over twenty years of sales and marketing experience prior to these roles, including over eight years with Baxter/American Hospital Supply Corporation. Mr. Myslinski also serves on the Board of MDxHealth, SA a publically traded company on the Belgium exchange (EuroNext MDXH).

Back